Cardiovascular risk factors and combined estrogen-progestin replacement therapy: a placebo-controlled study with nomegestrol acetate and estradiol
- 1 November 1995
- journal article
- clinical trial
- Published by Elsevier in Fertility and Sterility
- Vol. 64 (5) , 957-962
- https://doi.org/10.1016/s0015-0282(16)57909-6
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Association of Hormone-Replacement Therapy with Various Cardiovascular Risk Factors in Postmenopausal WomenNew England Journal of Medicine, 1993
- Effects of nomegestrol acetate (5 mg/d) on hormonal, metabolic and hemostatic parameters in premenopausal womenContraception, 1991
- Effects of Postmenopausal Estrogen Replacement on the Concentrations and Metabolism of Plasma LipoproteinsNew England Journal of Medicine, 1991
- Lipoprotein (a) concentrations in postmenopausal women taking norethisterone.BMJ, 1991
- Plasma Lp(a) concentration after oestrogen and progestagen in postmenopausal womenThe Lancet, 1991
- Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidencePreventive Medicine, 1991
- Continuous oestrogen-progestogen treatment and serum lipoproteins in postmenopausal womenBJOG: An International Journal of Obstetrics and Gynaecology, 1987
- Lipoprotein and apoprotein levels in postmenopausal women during treatment with norethisteroneClinica Chimica Acta; International Journal of Clinical Chemistry, 1986
- Reduction of lecithin-cholesterol acyltransferase, apolipoprotein D and the Lp(a) lipoprotein with the anabolic steroid stanozololBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1984
- Gerinnungsphysiologische Schnellmethode zur Bestimmung des FibrinogensActa Haematologica, 1957